Dr. John Tennis Keaveny is a Dickinson, North Dakota based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 669 12th St W, Suite 2, Dickinson. Patients can reach him at 701-225-5163.
Dr. John Tennis Keaveny deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. John Tennis Keaveny speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. John Tennis Keaveny
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
DDS OMS
Accepts Medicare Assignment:
May Accept
Practice Address:
669 12th St W, Suite 2, Dickinson, North Dakota, 58601-3554
Phone:
701-225-5163
Fax:
701-264-1032
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
9032102033
Enrollment ID:
I20090910000291
NPI Number:
1770584500
NPI Enumeration Date:
02 Aug, 2005
NPI Last Update On:
21 May, 2015
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
669 12th St W, Suite 2 Dickinson, North Dakota
Zip:
58601-3554
Phone Number:
701-225-5163
Fax Number:
701-264-1032
Patients can reach Dr. John Tennis Keaveny at 669 12th St W, Suite 2, Dickinson, North Dakota or can call to book an appointment on 701-225-5163. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.